Skip to content
Search

Latest Stories

Invest in pharmacy workforce: RPS Wales urges Senedd members

RPS’s latest Workforce Wellbeing Survey found that 88% of pharmacy team members in Wales face a high risk of burnout

RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.


The Wales-specific results highlighted that 88% of pharmacy team members are at high risk of burnout, driven by key factors such as inadequate staffing (73%), lack of work-life balance (46%), financial pressures (45%), and insufficient protected learning time (49%).

Medicine shortages are also significantly affecting mental health, with 60% of respondents reporting a negative impact on their wellbeing.

Additionally, the report identified workplace abuse as a serious concern, as 52% of respondents reported experiencing verbal abuse from the public.

In response, RPS Wales highlighted to MSs the urgent need for action, particularly in three key areas:

  • Investment in the pharmacy workforce, focusing on recruitment and retention.
  • Mandatory protected learning time, ensuring all pharmacy team members have dedicated time for professional development within their job plans.
  • Stronger public messaging to tackle verbal abuse by raising awareness of the evolving clinical role and pressures facing pharmacy teams.

RPS Wales Director, Elen Jones, said: “At a time when pharmacy teams are being asked to deliver transformational change through increased prescribing and clinical services, the survey underscores the urgent need for better support systems to enable professional development, combat burnout, and promote wellbeing.”

She welcomed the recognition from MSs of the vital role pharmacy teams play in healthcare and their understanding of the need for greater support.

“Building on these discussions, RPS will continue to engage with all political parties -particularly as they shape their priorities ahead of the upcoming Senedd election - to ensure the needs of pharmacy teams in Wales are met, ultimately leading to improved patient care,” she added.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less